Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute ...

A sample of 444 people will be recruited. The sample size calculation was based on assuming a level of significance of 5%, a quit rate after brief anti-smoking intervention only (control group) of ...

COPD Assessment Test (CAT) total scores showed that respiratory symptom burden had a greater negative impact on health status and daily activities of those with undiagnosed asthma vs. healthy ...

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...

Multifaceted remote interventions had a significant impact on patient outcomes in chronic obstructive pulmonary disease (COPD), a study published in the International Journal of Nursing Practice ...

Compared with those who tested negative, individuals with COPD who tested positive for COVID-19 had 9% overall higher HCU rates (rate ratio [RR], 1.096; 95% CI, 1.067-1.127), as well as a 13% higher ...

Drummond, M. B., et al. (2025). Use of a Digital Inhaler to Assess COPD Disease Variability and Identify Impending Acute COPD Exacerbations: A Pilot Study. Chronic Obstructive Pulmonary Diseases ...

Multiple Conditions Evidence Significant Associations In both the discovery and validation datasets, chronic obstructive pulmonary disease (COPD) was the strongest predictor of LCINS, according to the ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

James Baker, Sophie Booth, Josiah Dungwa, Andrew Higham, Dave Singh, Simon Lea. Alveolar macrophage carbon is associated with COPD severity. ERJ Open Research, 2025; 00933-2024 DOI: 10.1183 ...

Finerenone nominally appeared to improve NYHA class in patients with COPD, although not in those without COPD, from baseline to 12 months (Pinteraction =.048). Study limitations include lack of ...